Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 0 · FY2023 0 · FY2024 0
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2024 annual report, the company operates as a multi-specialty clinical hospital. 100% owned by SLC Hipocrate (ID 404919406). Located in Didube, Lublianas Street #33, Tbilisii.
Subsidiary of Hippocrates (100.0%)
| Ratio | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross Margin | 78.8% | 78.0% | 76.9% | 81.5% | 71.8% | 78.4% | 73.7% | 72.7% |
| EBITDA Margin | 62.8% | 6.0% | 0.8% | 19.4% | 16.9% | -3.3% | -6.6% | -27.5% |
| EBITDAR | 8,262 | 861 | 97 | 2,750 | 3,524 | -380 | -891 | -4,194 |
| EBITDAR Margin | 62.8% | 6.0% | 0.8% | 19.4% | 16.9% | -3.3% | -6.6% | -27.5% |
| EBIT Margin | 52.1% | -3.4% | -9.2% | 10.7% | 11.2% | -10.3% | -14.9% | -36.0% |
| Net Profit Margin | -10.7% | -3.8% | -10.2% | 2.5% | 13.1% | -5.5% | -18.3% | -40.0% |
| Operating Expense % of Sales | 16.1% | 72.1% | 76.1% | 62.1% | 54.9% | 81.7% | 96.2% | 108.8% |
| Returns | ||||||||
| Return on Assets (ROA) | -6.5% | -2.6% | -5.9% | 1.5% | 9.0% | -2.1% | -7.9% | -18.2% |
| Return on Equity (ROE) | -9.5% | -4.0% | -10.5% | 2.8% | 12.6% | -3.0% | -13.4% | -49.3% |
| ROIC [EBIT / Invested Capital] | 38.0% | -2.9% | -7.0% | 8.3% | 9.4% | -4.7% | -7.8% | -24.8% |
| Leverage & debt balances | ||||||||
| Debt-to-Assets | 16.5% | 15.3% | 20.0% | 26.2% | 15.6% | 15.7% | 24.0% | 29.5% |
| Debt-to-Equity | 0.24x | 0.24x | 0.35x | 0.49x | 0.22x | 0.22x | 0.41x | 0.80x |
| Debt-to-EBITDA | 0.43x | 3.76x | 43.80x | 2.20x | 1.34x | N/A | N/A | N/A |
| Equity-to-Assets | 68.2% | 64.6% | 56.5% | 53.6% | 71.2% | 71.1% | 59.2% | 37.0% |
| Net Debt | 3,310 | 3,195 | 4,148 | 5,885 | 3,165 | 4,047 | 7,288 | 9,702 |
| Cash & Equivalents | 250 | 39 | 113 | 157 | 1,565 | 574 | 207 | 172 |
| Total Debt | 3,560 | 3,234 | 4,261 | 6,042 | 4,731 | 4,620 | 7,495 | 9,874 |
| Liquidity & working capital | ||||||||
| Current Ratio | 3.20x | 1.32x | 1.34x | 1.75x | 2.48x | 2.45x | 2.13x | 1.13x |
| Quick Ratio | 2.92x | 1.22x | 1.25x | 1.45x | 1.93x | 1.83x | 1.66x | 0.91x |
| Cash Ratio | 0.16x | 0.01x | 0.02x | 0.03x | 0.39x | 0.15x | 0.04x | 0.02x |
| Total Current Assets | 4,950 | 5,621 | 6,705 | 8,176 | 9,942 | 9,576 | 11,161 | 12,693 |
| Total Current Liabilities | 1,548 | 4,244 | 5,016 | 4,662 | 4,013 | 3,910 | 5,240 | 11,192 |
| Inventory | 437 | 451 | 413 | 1,427 | 2,183 | 2,428 | 2,455 | 2,462 |
| Trade Receivables | 3,367 | 4,225 | 5,079 | 5,583 | 5,242 | 5,423 | 6,483 | 6,094 |
| Trade Payables | 1,387 | 1,663 | 1,638 | 1,995 | 1,960 | 1,439 | 2,423 | 4,554 |
| Net Working Capital | 3,402 | 1,378 | 1,688 | 3,514 | 5,929 | 5,666 | 5,921 | 1,501 |
| Net Working Capital % of Revenue | 25.8% | 9.6% | 13.6% | 24.7% | 28.4% | 49.5% | 43.8% | 9.8% |
| Trade Working Capital | 2,417 | 3,013 | 3,854 | 5,015 | 5,466 | 6,412 | 6,516 | 4,001 |
| Trade Working Capital % of Revenue | 18.4% | 20.9% | 31.1% | 35.3% | 26.2% | 56.0% | 48.2% | 26.2% |
| Change in Trade Working Capital | N/A | 596 | 841 | 1,161 | 451 | 946 | 104 | -2,515 |
| Turnover & efficiency | ||||||||
| Inventory Turnover | 6.39x | 7.02x | 6.93x | 1.85x | 2.69x | 1.02x | 1.45x | 1.69x |
| Days Inventory Outstanding (DIO) | 57.1 | 52.0 | 52.7 | 197.7 | 135.4 | 357.8 | 252.6 | 216.0 |
| Receivables Turnover | 3.91x | 3.41x | 2.44x | 2.54x | 3.98x | 2.11x | 2.08x | 2.50x |
| Days Sales Outstanding (DSO) | 93.4 | 106.9 | 149.8 | 143.5 | 91.8 | 172.9 | 175.2 | 145.8 |
| Payables Turnover | 2.01x | 1.90x | 1.75x | 1.32x | 3.00x | 1.72x | 1.46x | 0.91x |
| Days Payable Outstanding (DPO) | 181.4 | 191.7 | 208.8 | 276.5 | 121.6 | 212.1 | 249.2 | 399.6 |
| Cash Conversion Cycle | -30.9 days | -32.7 days | -6.3 days | 64.7 days | 105.6 days | 318.7 days | 178.5 days | -37.9 days |
| Asset Turnover | 0.61x | 0.68x | 0.58x | 0.62x | 0.69x | 0.39x | 0.43x | 0.46x |
| Cash flow & dividends | ||||||||
| Operating Cash Flow | 1,124 | 1,532 | 1,472 | 966 | 2,356 | -1,395 | -1,727 | -490 |
| Free Cash Flow (OCF − Capex proxy) | 1,124 | 1,041 | -372 | -501 | 2,356 | -1,395 | -2,705 | 1,691 |
| Cash Conversion (OCF / EBITDA) | 13.6% | 178.0% | 1513.2% | 35.1% | 66.9% | N/A | N/A | N/A |
| Dividends Declared | 1,220 | 526 | 170 | 0 | 0 | 0 | 0 | 0 |
| Dividend Payout Ratio | N/A | N/A | N/A | 0.0% | 0.0% | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →